Clinical Trial Update: Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 clinical trial evaluating the efficacy and safety of SHR0302 ointment for vitiligo has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• SHR0302 ointment

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Vitiligo | Phase 2, Phase 3 | Status: TERMINATED